Dragon Blood®

📍 Washington DC, United States👥 5 employees💰 Last funded 2018
Biotechnology Research🌐 linkedin.com
Website LinkedIn
Edible extremophiles to enhance the immune system's adaptive responses. We are also engineering Komodo Dragon - sangre de Smaug - and American Alligator anitmicrobial peptides for use in antibiotic-resistance. We're engineering performance enhancerment supplements via Extremophiles (Acidophile, Alakaliphiles, Thermophile, Psychrophile, Xerophile, Barophile (Piezophile), Halophile, Snottite, Giant Tube Worms, Tardigrades, Loricifera, Grylloblattidae).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Dragon Blood®?
Dragon Blood® has 1 investor on record on gritt.io.
When did Dragon Blood® last raise funding?
The most recent investment in Dragon Blood® recorded on gritt.io was in 2018.
What industry is Dragon Blood® in?
Dragon Blood® operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Dragon Blood® based?
Dragon Blood® is headquartered in Washington DC, United States.